TACROLIMUS ANHYDROUS
Substance profile for UNII Y5L2157C4J, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 445643Substance Identity#
- UNII
- Y5L2157C4J
- Preferred term
- TACROLIMUS ANHYDROUS
- Registry number
- 104987-11-3
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C44H69NO12
Chemical And Database Identifiers#
- InChIKey
- QJJXYPPXXYFBGM-LFZNUXCKSA-N
- SMILES
- CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC
- RxCUI
- 235991
- PubChem
- 445643
- NCIt
- C76066
- INN ID
- 6878
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | These highlights do not include all the information needed to use PROGRAF safely and effectively. See full prescribing information for PROGRAF. PROGRAF ® (tacrolimus) capsules, USP PROGRAF ® (tacrolimus) injection, (for intravenous use) Initial U.S. Approval: 1994 | 1 | |
| anhydrous tacrolimus | ACTIVE INGREDIENT | Y5L2157C4J | PROGRAF® tacrolimus capsules tacrolimus injection (for intravenous infusion only) | 1 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE, GELATIN COATED [BRYANT RANCH PREPACK] | 1000 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | PROGRAF (TACROLIMUS) CAPSULE, GELATIN COATED PROGRAF (TACROLIMUS) INJECTION, SOLUTION [ASTELLAS PHARMA US, INC.] | 15 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [WATSON LABORATORIES, INC.] | 11 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | PROTOPIC (TACROLIMUS) OINTMENT [ASTELLAS PHARMA US INC.] | 10 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [SANDOZ INC] | 10 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE, GELATIN COATED [KREMERS URBAN PHARMACEUTICALS INC.] | 9 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | HECORIA (TACROLIMUS) CAPSULE [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 | |
| tacrolimus anhydrous | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [DR. REDDY'S LABORATORIES LIMITED] | 7 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS OINTMENT [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 7 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [SANDOZ INC] | 6 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [ACCORD HEALTHCARE INC.] | 5 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [AMERICAN HEALTH PACKAGING] | 5 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [CARDINAL HEALTH] | 5 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [STRIDES ARCOLAB LIMITED] | 5 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | ASTAGRAF XL (TACROLIMUS EXTENDED-RELEASE CAPSULES) CAPSULE, COATED, EXTENDED RELEASE [ASTELLAS PHARMA US, INC.] | 4 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [MYLAN PHARMACEUTICALS INC.] | 4 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | ENVARSUS XR (TACROLIMUS) TABLET, EXTENDED RELEASE [VELOXIS PHARMACEUTICALS, INC] | 3 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [CARDINAL HEALTH] | 2 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [MYLAN INSTITUTIONAL INC.] | 2 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS OINTMENT [PERRIGO NEW YORK INC] | 2 | |
| TACROLIMUS ANHYDROUS | ACTIVE INGREDIENT | Y5L2157C4J | PROGRAF (TACROLIMUS) CAPSULE, GELATIN COATED [CARDINAL HEALTH] | 1 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [CARDINAL HEALTH] | 1 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [CARDINAL HEALTH] | 1 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [INGENUS PHARMACEUTICALS, LLC] | 1 | |
| ANHYDROUS TACROLIMUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [KAISER FOUNDATION HOSPITALS] | 1 | |
| TACROLIMUS ANHYDROUS | ACTIVE MOIETY | Y5L2157C4J | TACROLIMUS CAPSULE [MAJOR PHARMACEUTICALS] | 1 | |